Drug intelligence / Profile preview

glucose (Unique Pharmaceutical Laboratories Limited)

Development stage
Unknown
Lead developer
Unique Pharmaceuticals
Modality
Small Molecules
Administration
Intravenous
01

Overview

Unidex-5 is an intravenous infusion solution containing 5% glucose (dextrose) in water, manufactured by Unique Pharmaceuticals. It is widely used in clinical settings for fluid replacement, hydration, and as a source of carbohydrates and calories for patients who cannot maintain adequate oral intake. It is also indicated for the treatment of hypoglycemia. Upon administration, glucose is transported into cells via glucose transporters (such as GLUT1, GLUT2, and GLUT4) and phosphorylated by hexokinases to enter glycolysis, providing essential cellular energy and maintaining hydration without causing significant electrolyte imbalances.

Brand names
Unidex-5Unidex5Unidex 5
Other names
5% dextrose in waterD-glucoseD5WD-5WD 5Wdextrosedextrose 5% in waterglucose 5% infusion
02

Targets

HK1 (Hexokinase type I (mitochondrial))SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)GCK (Glucokinase)SLC2A2 (Solute carrier family 2 facilitated glucose transporter member 2)GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on glucose (Unique Pharmaceutical Laboratories Limited).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucose (Unique Pharmaceutical Laboratories Limited).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call